Clinical Trials Directory

Trials / Sponsors / Genocea Biosciences, Inc.

Genocea Biosciences, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedTiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck
Phase 12020-11-11
CompletedSafety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Cutaneous Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck
Phase 1 / Phase 22018-08-29
TerminatedMaintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
Genital Herpes, HSV-2 Infection
Phase 22017-05-24
CompletedLong-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Genital Herpes Simplex Type 2
—2016-09-16
CompletedEvaluating New Formulation of Therapeutic HSV-2 Vaccine
Genital Herpes Simplex Type 2
Phase 22015-11-01
CompletedRollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study
Genital Herpes Simplex Type 2
Phase 22015-01-01
CompletedSafety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pne
Pneumococcal Infections, Pneumonia, Pneumococcal
Phase 22014-09-01
CompletedDose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Genital Herpes Simplex Type 2
Phase 22014-07-01
CompletedSafety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine
Streptococcus Pneumoniae
Phase 12013-11-01
CompletedSafety and Immunogenicity Study of Therapeutic HSV-2 Vaccine
Genital Herpes Simplex Type 2
Phase 1 / Phase 22012-07-01